Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
NCF1-dependent production of ROS protects against lupus by regulating plasmacytoid dendritic cell development and functions
Huqiao Luo, Vilma Urbonaviciute, Amir Ata Saei, Hezheng Lyu, Massimiliano Gaetani, Ákos Végvári, Yanpeng Li, Roman A. Zubarev, Rikard Holmdahl
Huqiao Luo, Vilma Urbonaviciute, Amir Ata Saei, Hezheng Lyu, Massimiliano Gaetani, Ákos Végvári, Yanpeng Li, Roman A. Zubarev, Rikard Holmdahl
View: Text | PDF
Research Article

NCF1-dependent production of ROS protects against lupus by regulating plasmacytoid dendritic cell development and functions

  • Text
  • PDF
Abstract

Low capacity to produce ROS because of mutations in neutrophil cytosolic factor 1 (NCF1/p47phox), a component of NADPH oxidase 2 (NOX2) complex, is strongly associated with systemic lupus erythematosus in both humans and mouse models. Here, we aimed to identify the key immune cell type(s) and cellular mechanisms driving lupus pathogenesis under the condition of NCF1-dependent ROS deficiency. Using cell-specific Cre-deleter, human NCF1-339 variant knockin, and transgenic mouse strains, we show that low ROS production in plasmacytoid dendritic cells (pDCs) exacerbated both pristane-induced lupus and a potentially new Y-linked autoimmune accelerating locus–related spontaneous model by promoting pDC accumulation in multiple organs during lupus development, accompanied by elevated IFN-α levels and expression of IFN-stimulated genes. Mechanistic studies revealed that ROS deficiency enhanced pDC generation through the AKT/mTOR pathway and CCR2-mediated migration to tissues, which together with hyperactivation of the redox-sensitive stimulator of interferon genes/IFN-α/JAK1/STAT1 cascade further augmented type I IFN responses. More importantly, by suppressing these pathways, restoration of NOX2-derived ROS specifically in pDCs protected against lupus. These discoveries explain the causative effect of dysfunctional NCF1 in lupus and demonstrate the protective role of pDC-derived ROS in disease development driven by NCF1-dependent ROS deficiency.

Authors

Huqiao Luo, Vilma Urbonaviciute, Amir Ata Saei, Hezheng Lyu, Massimiliano Gaetani, Ákos Végvári, Yanpeng Li, Roman A. Zubarev, Rikard Holmdahl

×

Figure 8

ROS-deficient pDCs with hyperactivated STING/IFN-α/JAK1/STAT1 cascade exacerbate PIL.

Options: View larger image (or click on image) Download as PowerPoint
ROS-deficient pDCs with hyperactivated STING/IFN-α/JAK1/STAT1 cascade ex...
(A and B) IFN-α production by BM-derived pDCs from B10.Q and B10.Q.Ncf1m1j/m1j mice upon 24-hour stimulation by (A) TLR7/9 agonists and (B) cGAMP. (C) IFN-α production by BM-derived pDCs from B10.Q and B10.Q.Ncf1m1j/m1j mice upon 20-hour stimulation by IFN-α. (D) P-STAT1 in BM-derived pDCs from B10.Q and B10.Q.Ncf1m1j/m1j mice upon 30-minute stimulation by IFN-α. Representative histograms are presented. (E) Expression of ISGs in BM-derived pDCs from B10.Q and B10.Q.Ncf1m1j/m1j mice upon 4-hour stimulation by IFN-α. (F) P-STAT1 in BM-derived pDCs from B10.Q and B10.Q.Ncf1m1j/m1j mice with or without H2O2 upon 30-minute stimulation by IFN-α. (G) P-JAK1 in BM-derived pDCs from B10.Q and B10.Q.Ncf1m1j/m1j mice upon stimulation by IFN-α for indicated times. (H) Serum levels of autoantibodies against dsDNA, nucleosomes, Sm/RNP, and cardiolipin and (I) urinary protein concentrations in Balb/c mice receiving Balb/c pDCs and Balb/c mice receiving Balb/c.Ncf1m1j/m1j pDCs (n = 7) at different time points after pristane injection. (J) Frequency and numbers of CD45+ cells within kidneys from Balb/c mice receiving Balb/c pDCs and Balb/c mice receiving Balb/c.Ncf1m1j/m1j pDCs (n = 7) at 5 MPI. Representative plots are presented. Two-way ANOVA with Holm-Šídák multiple-comparison test (A–E and G–I), 1-way ANOVA with Tukey’s multiple-comparison test (F), and 2-tailed Mann-Whitney U test (J). *P < 0.05, **P < 0.01, ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts